Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease

doi:10.4239/wjd.v6.i11.1186

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8690)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

406

WORD

292

HTML

3168

Figures (1-5)

181

Sum=4047

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

646

Download

1738

Sum=2384

Publishing Process of This Article

Item

Count

Browse

953

Download

1306

Sum=2259

Sep 10, 2015 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Sep 10, 2015; 6(11): 1186-1197
Published online Sep 10, 2015. doi: 10.4239/wjd.v6.i11.1186

Full Size Figure Download Figure

Figure 5 Flowchart of the clinical investigational trials which are completed or ongoing.

Citation: Sanchez RA, Sanabria H, Santos CL, Ramirez AJ. Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease. World J Diabetes 2015; 6(11): 1186-1197
URL: https://www.wjgnet.com/1948-9358/full/v6/i11/1186.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i11.1186